Prime Medicine, Inc. (PRME) — 8-K Filings

8-K Filings (20)

• 8-K Filing — May 7, 2026
• Prime Medicine Files 8-K — Sep 8, 2025 Risk: low
  Prime Medicine, Inc. filed an 8-K on September 8, 2025, to report on matters including Regulation FD Disclosure and Financial Statements and Exhibits. The compa
• Prime Medicine Reports Director, Officer, and Shareholder Votes — Aug 5, 2025 Risk: medium
  Prime Medicine, Inc. filed an 8-K on August 5, 2025, reporting events as of August 1, 2025. The filing indicates changes related to the departure and election o
• Prime Medicine, Inc. Enters Material Definitive Agreement — Jul 31, 2025 Risk: medium
  On July 30, 2025, Prime Medicine, Inc. entered into a material definitive agreement. The filing does not provide details on the agreement's nature or any associ
• Prime Medicine Files 8-K on Operations and Financials — Jul 30, 2025 Risk: low
  Prime Medicine, Inc. filed an 8-K on July 30, 2025, reporting on its results of operations and financial condition, as well as other events. The filing also inc
• Prime Medicine Appoints New Directors, Adjusts Executive Pay — Jul 15, 2025 Risk: medium
  Prime Medicine, Inc. announced on July 14, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directo
• Prime Medicine Files 8-K on Shareholder Votes and Exhibits — Jun 5, 2025 Risk: low
  Prime Medicine, Inc. filed an 8-K on June 5, 2025, reporting on matters submitted to a vote of security holders and filing financial statements and exhibits. Th
• Prime Medicine Reports Director Changes and Officer Appointments — May 19, 2025 Risk: low
  Prime Medicine, Inc. filed an 8-K on May 19, 2025, reporting on the departure of a director, the election of new directors, and the appointment of certain offic
• Prime Medicine Files 8-K — Mar 18, 2025 Risk: low
  Prime Medicine, Inc. filed an 8-K on March 18, 2025, reporting on other events and financial statements. The filing does not contain specific financial figures
• Prime Medicine Files 8-K — Jan 13, 2025 Risk: low
  On January 13, 2025, Prime Medicine, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No
• Prime Medicine Files 8-K on Financials — Nov 12, 2024 Risk: low
  Prime Medicine, Inc. filed an 8-K on November 12, 2024, reporting on its results of operations and financial condition. The filing includes financial statements
• Prime Medicine Files 8-K — Oct 24, 2024 Risk: low
  Prime Medicine, Inc. filed an 8-K on October 24, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain s
• Prime Medicine Files 8-K: Agreements, Sales, and Financials — Sep 30, 2024 Risk: medium
  Prime Medicine, Inc. filed an 8-K on September 30, 2024, reporting on several items including the entry into a material definitive agreement, unregistered sales
• Prime Medicine Files 8-K on Financials — Aug 8, 2024 Risk: low
  Prime Medicine, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial statements an
• Prime Medicine Files 8-K — Jun 12, 2024 Risk: low
  Prime Medicine, Inc. filed an 8-K on June 12, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing does not d
• Prime Medicine Files 8-K with Corporate Updates — May 21, 2024 Risk: low
  Prime Medicine, Inc. filed an 8-K on May 21, 2024, reporting events as of May 17, 2024. The filing primarily concerns amendments to its Articles of Incorporatio
• Prime Medicine Enters Material Definitive Agreement — Feb 16, 2024 Risk: medium
  Prime Medicine, Inc. filed an 8-K on February 16, 2024, reporting an event that occurred on February 14, 2024. The filing indicates the entry into a material de
• Prime Medicine Files 8-K on Financial Condition — Feb 14, 2024 Risk: low
  Prime Medicine, Inc. (CIK: 0001894562) filed an 8-K on February 14, 2024, to report on its "Results of Operations and Financial Condition." This filing, with SE
• Prime Medicine Confirms Emerging Growth Company Status — Jan 8, 2024
  Prime Medicine, Inc. filed an 8-K on January 8, 2024, to disclose that it is an "emerging growth company" as defined by the SEC. This status allows the company
• Prime Medicine Reports Officer/Director Changes & Comp Arrangements — Jan 5, 2024
  Prime Medicine, Inc. filed an 8-K on January 5, 2024, reporting an event that occurred on January 4, 2024, related to the 'Departure of Directors or Certain Off

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX